China Foods Holdings Reports Revenue Collapse to $255 and Ineffective Disclosure Controls
CFOO has more than doubled off its 52-week low of $0.05.
Summary
China Foods Holdings reported a near-total revenue collapse to $255 for H1 2026 and ineffective disclosure controls, while relying on controlling shareholder support to address going concern.
Key Events · Earnings and Guidance · CFOO
-
Revenue Collapse
Revenue for the six months ended June 30, 2026 was $255, down from $142,255 in the prior-year period. Healthcare product sales fell to $77 from $142,171.
-
Ineffective Disclosure Controls
Management concluded disclosure controls and procedures were not effective as of June 30, 2026, meaning information may not be recorded, processed, or reported accurately.
-
Going Concern Assessment
Current liabilities exceeded current assets by $1,451,924 and accumulated deficit was $2,655,563. Management concluded no substantial doubt about going concern due to controlling shareholder support agreements.
-
Controlling Shareholder Support
The controlling shareholder entered into legally binding, unconditional, and enforceable agreements to provide financial support for at least the next 12 months.
Analysis · CFOO · Life Sciences
Revenue fell to $255 for the first half of 2026 from $142,255 a year earlier, a near-total collapse in sales. Management also concluded disclosure controls and procedures were not effective as of June 30, 2026. The company has a working capital deficit of $1.45 million and an accumulated deficit of $2.66 million, but the controlling shareholder has provided legally binding financial support for at least 12 months, which management says removes substantial doubt about going concern.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 34.9% of the 1020 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.54%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CFOO was trading at $0.66 on OTC in the Life Sciences sector, with a market capitalization of approximately $13.4M. The 52-week trading range was $0.05 to $11.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.